SCHEMBL7970843

SCHEMBL7970843

Nc1cc2c(=O)[nH]cnc2cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.59
IP6K1 Q92551 5/20 0.54
KDM4A O75164 1/20 0.51
KDM4B O94953 1/20 0.51
KDM5C P41229 1/20 0.51
KDM4C Q9H3R0 1/20 0.51
KDM5B Q9UGL1 1/20 0.51
KDM3A Q9Y4C1 1/20 0.51
CHEK1 O14757 2/20 0.50
PIM1 P11309 2/20 0.50
AKT1 P31749 1/20 0.50
FLT3 P36888 1/20 0.50
PIM3 Q86V86 1/20 0.50
MKNK1 Q9BUB5 1/20 0.49
PDPK1 O15530 1/20 0.47
CA12 O43570 1/20 0.47
ALOX15 P16050 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA9 Q16790 1/20 0.47
TNKS2 Q9H2K2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837616 0.85 PARP1 (0.54) PARP1IP6K1KDM4AKDM4BKDM5C
SCHEMBL869256 0.78 PARP1 (0.59) PARP1IP6K1KDM4AKDM4BKDM5C
SCHEMBL7657502 0.78 PARP1 (0.59) PARP1IP6K1KDM4AKDM4BKDM5C
SCHEMBL669366 0.78 PARP1 (0.59) PARP1IP6K1KDM4AKDM4BKDM5C
SCHEMBL7221768 0.77 PARP1 (0.62) PARP1IP6K1CHEK1PIM1AKT1
SCHEMBL6360085 0.76 IP6K1 (0.52) PARP1IP6K1KDM4AKDM4BKDM5C
SCHEMBL2081677 0.74 PARP1 (1.00) PARP1IP6K1CHEK1PIM1AKT1
SCHEMBL6769666 0.74 IP6K1 (0.50) PARP1IP6K1KDM4AKDM4BKDM5C
SCHEMBL21331974 0.74 PARP1 (0.54) PARP1IP6K1KDM4AKDM4BKDM5C
SCHEMBL6364139 0.74 PARP1 (0.50) PARP1IP6K1KDM4AKDM4BKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174889-B1 PROTEIN TYROSINE KINASE INHIBITORS RELATED TO BIOISOSTERES OF QUINOLINE AND QUINAZOLINE DERIVATIVES; ANTICARCINOGENIC AND -TUMOR AGENTS; PSORIASIS; RESTENOSIS; RHEUMATOID ARTHRITIS, AUTOIMMUNE DISEASE, ALLERGY, ASTHMA AND GRAFT REJECTION GLAXO WELLCOME INC. 2001-01-16 US claimed